TY - JOUR AU - Zhu, N. AU - Zhang, D. AU - Wang, W. PY - 2020 DA - 2020// TI - A novel coronavirus from patients with pneumonia in China, 2019 JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMoa2001017 DO - 10.1056/NEJMoa2001017 ID - Zhu2020 ER - TY - STD TI - Organization WH. clinical-management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected-interim guidance. Published January 28, 2020. ID - ref2 ER - TY - JOUR AU - Qiu, H. AU - Tong, Z. AU - Ma, P. PY - 2020 DA - 2020// TI - Intensive care during the coronavirus epidemic JO - Intensive Care Med UR - https://doi.org/10.1007/s00134-020-05966-y DO - 10.1007/s00134-020-05966-y ID - Qiu2020 ER - TY - JOUR AU - Hui, D. S. AU - Azhar, I. AU - Madani, T. A. PY - 2019 DA - 2019// TI - The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest, novel coronavirus outbreak in Wuhan, China JO - Int J Infect Dis. VL - 2020 ID - Hui2019 ER - TY - JOUR AU - Lu, R. AU - Zhao, X. AU - Li, J. PY - 2020 DA - 2020// TI - Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30251-8 DO - 10.1016/S0140-6736(20)30251-8 ID - Lu2020 ER - TY - JOUR AU - Yu, Y. X. AU - Sun, L. AU - Yao, K. PY - 2020 DA - 2020// TI - Consideration and prevention for the aerosol transmission of 2019 novel coronavirus JO - Zhonghua Yan Ke Za Zhi. VL - 56 ID - Yu2020 ER - TY - JOUR AU - Doremalen, N. AU - Bushmaker, T. AU - Morris, D. H. PY - 2020 DA - 2020// TI - Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 JO - N Engl J Med UR - https://doi.org/10.1056/NEJMc2004973 DO - 10.1056/NEJMc2004973 ID - Doremalen2020 ER - TY - JOUR AU - Wang, Z. AU - Chen, X. AU - Lu, Y. PY - 2020 DA - 2020// TI - Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment JO - Biosci Trends. UR - https://doi.org/10.5582/bst.2020.01030 DO - 10.5582/bst.2020.01030 ID - Wang2020 ER - TY - JOUR AU - Arabi, Y. M. AU - Fowler, R. AU - Hayden, F. G. PY - 2020 DA - 2020// TI - Critical care management of adults with community-acquired severe respiratory viral infection JO - Intens Care Med UR - https://doi.org/10.1007/s00134-020-05943-5 DO - 10.1007/s00134-020-05943-5 ID - Arabi2020 ER - TY - JOUR AU - Booth, C. M. AU - Matukas, L. M. AU - Tomlinson, G. A. PY - 2003 DA - 2003// TI - Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area JO - JAMA VL - 289 UR - https://doi.org/10.1001/jama.289.21.JOC30885 DO - 10.1001/jama.289.21.JOC30885 ID - Booth2003 ER - TY - JOUR AU - Lee, N. AU - Hui, D. AU - Wu, A. PY - 2003 DA - 2003// TI - A major outbreak of severe acute respiratory syndrome in Hong Kong JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa030685 DO - 10.1056/NEJMoa030685 ID - Lee2003 ER - TY - JOUR AU - Sun, P. AU - Qie, S. AU - Liu, Z. PY - 2020 DA - 2020// TI - Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection JO - J Med Virol UR - https://doi.org/10.1002/jmv.25735 DO - 10.1002/jmv.25735 ID - Sun2020 ER - TY - JOUR AU - Wang, D. AU - Hu, B. PY - 2020 DA - 2020// TI - Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China JO - JAMA. UR - https://doi.org/10.1001/jama.2020.1585 DO - 10.1001/jama.2020.1585 ID - Wang2020 ER - TY - JOUR AU - Wang, Y. AU - Fan, G. AU - Salam, A. PY - 2019 DA - 2019// TI - Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection JO - J Infect Dis UR - https://doi.org/10.1093/infdis/jiz656 DO - 10.1093/infdis/jiz656 ID - Wang2019 ER - TY - JOUR AU - Kim, U. J. AU - Won, E. J. AU - Kee, S. J. PY - 2016 DA - 2016// TI - Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome JO - Antivir Ther. VL - 21 UR - https://doi.org/10.3851/IMP3002 DO - 10.3851/IMP3002 ID - Kim2016 ER - TY - JOUR AU - Omrani, A. S. AU - Saad, M. M. AU - Baig, K. PY - 2014 DA - 2014// TI - Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study JO - Lancet Infect Dis. VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70920-X DO - 10.1016/S1473-3099(14)70920-X ID - Omrani2014 ER - TY - JOUR AU - Chu, C. M. AU - Cheng, V. C. AU - Hung, I. F. PY - 2004 DA - 2004// TI - Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings JO - Thorax VL - 59 UR - https://doi.org/10.1136/thorax.2003.012658 DO - 10.1136/thorax.2003.012658 ID - Chu2004 ER - TY - JOUR AU - Cao, B. AU - Wang, Y. AU - Wen, D. PY - 2020 DA - 2020// TI - A Trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 JO - N Engl J Med UR - https://doi.org/10.1056/NEJMoa2001282 DO - 10.1056/NEJMoa2001282 ID - Cao2020 ER - TY - JOUR AU - Mulangu, S. AU - Dodd, L. E. AU - Davey, R. T. PY - 2019 DA - 2019// TI - A randomized, controlled trial of ebola virus disease therapeutics JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1910993 DO - 10.1056/NEJMoa1910993 ID - Mulangu2019 ER - TY - JOUR AU - Gordon, C. J. AU - Tchesnokov, E. P. AU - Feng, J. Y. PY - 2020 DA - 2020// TI - The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus JO - J Biol Chem UR - https://doi.org/10.1074/jbc.AC120.013056 DO - 10.1074/jbc.AC120.013056 ID - Gordon2020 ER - TY - JOUR AU - Wit, E. AU - Feldmann, F. AU - Cronin, J. PY - 2020 DA - 2020// TI - Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection JO - Proc Natl Acad Sci USA UR - https://doi.org/10.1073/pnas.1922083117 DO - 10.1073/pnas.1922083117 ID - Wit2020 ER - TY - JOUR AU - Sheahan, T. P. AU - Sims, A. C. AU - Leist, S. R. PY - 2020 DA - 2020// TI - Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV JO - Nat Communs. VL - 11 UR - https://doi.org/10.1038/s41467-019-13940-6 DO - 10.1038/s41467-019-13940-6 ID - Sheahan2020 ER - TY - JOUR AU - Holshue, M. L. AU - DeBolt, C. AU - Lindquist, S. PY - 2020 DA - 2020// TI - First case of 2019 novel coronavirus in the United States JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMoa2001191 DO - 10.1056/NEJMoa2001191 ID - Holshue2020 ER - TY - STD TI - Cao B. Mild/moderate 2019-nCoV remdesivir RCT—Full Text View ClinicalTrials.gov. 2020. https://clinicaltrials.gov/ct2/show/NCT04252664. Accessed 13 Feb 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04252664 ID - ref24 ER - TY - STD TI - Cao B. Severe 2019-nCoV remdesivir RCT—Full text view—ClinicalTrials.gov. 2020. https://clinicaltrials.gov/ct2/show/NCT04257656. Accessed 13 Feb 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04257656 ID - ref25 ER - TY - JOUR AU - Blaising, J. AU - Polyak, S. J. AU - Pecheur, E. I. PY - 2014 DA - 2014// TI - Arbidol as a broad-spectrum antiviral: an update JO - Antiviral Res VL - 107 UR - https://doi.org/10.1016/j.antiviral.2014.04.006 DO - 10.1016/j.antiviral.2014.04.006 ID - Blaising2014 ER - TY - JOUR AU - Boriskin, Y. S. AU - Leneva, I. A. AU - Pecheur, E. I. PY - 2008 DA - 2008// TI - Arbidol: a broad-spectrum antiviral compound that blocks viral fusion JO - Curr Med Chem VL - 15 UR - https://doi.org/10.2174/092986708784049658 DO - 10.2174/092986708784049658 ID - Boriskin2008 ER - TY - JOUR AU - Khamitov, R. A. AU - Loginova, S. AU - Shchukina, V. N. PY - 2008 DA - 2008// TI - Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures JO - Vopr Virusol VL - 53 ID - Khamitov2008 ER - TY - JOUR AU - Lu, H. PY - 2020 DA - 2020// TI - Drug treatment options for the 2019-new coronavirus (2019-nCoV) JO - Biosci Trends. UR - https://doi.org/10.5582/bst.2020.01020 DO - 10.5582/bst.2020.01020 ID - Lu2020 ER - TY - STD TI - Qu J. Clinical study of arbidol hydrochloride tablets in the treatment of pneumonia caused by novel coronavirus, 2020. https://clinicaltrials.gov/ct2/show/NCT04260594. Accessed 7 Feb 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04260594 ID - ref30 ER - TY - JOUR AU - Li, W. AU - Moore, M. J. AU - Vasilieva, N. PY - 2003 DA - 2003// TI - Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus JO - Nature VL - 426 UR - https://doi.org/10.1038/nature02145 DO - 10.1038/nature02145 ID - Li2003 ER - TY - JOUR AU - Dimitrov, D. S. PY - 2003 DA - 2003// TI - The secret life of ACE2 as a receptor for the SARS virus JO - Cell VL - 115 UR - https://doi.org/10.1016/S0092-8674(03)00976-0 DO - 10.1016/S0092-8674(03)00976-0 ID - Dimitrov2003 ER - TY - JOUR AU - Simmons, G. AU - Reeves, J. D. AU - Rennekamp, A. J. PY - 2004 DA - 2004// TI - Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry JO - Proc Natl Acad Sci USA VL - 101 UR - https://doi.org/10.1073/pnas.0306446101 DO - 10.1073/pnas.0306446101 ID - Simmons2004 ER - TY - JOUR AU - Yeung, K. S. AU - Yamanaka, G. A. AU - Meanwell, N. A. PY - 2006 DA - 2006// TI - Severe acute respiratory syndrome coronavirus entry into host cells: opportunities for therapeutic intervention JO - Med Res Rev VL - 26 UR - https://doi.org/10.1002/med.20055 DO - 10.1002/med.20055 ID - Yeung2006 ER - TY - JOUR AU - Yan, Y. AU - Zou, Z. AU - Sun, Y. PY - 2013 DA - 2013// TI - Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model JO - Cell Res VL - 23 UR - https://doi.org/10.1038/cr.2012.165 DO - 10.1038/cr.2012.165 ID - Yan2013 ER - TY - JOUR AU - Vincent, M. J. AU - Bergeron, E. AU - Benjannet, S. PY - 2005 DA - 2005// TI - Chloroquine is a potent inhibitor of SARS coronavirus infection and spread JO - Virol J. VL - 2 UR - https://doi.org/10.1186/1743-422X-2-69 DO - 10.1186/1743-422X-2-69 ID - Vincent2005 ER - TY - JOUR AU - Xu, H. AU - Zhong, L. AU - Deng, J. PY - 2020 DA - 2020// TI - High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa JO - Int J Oral Sci. VL - 12 UR - https://doi.org/10.1038/s41368-020-0074-x DO - 10.1038/s41368-020-0074-x ID - Xu2020 ER - TY - JOUR AU - Wang, M. AU - Cao, R. AU - Zhang, L. PY - 2020 DA - 2020// TI - Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro JO - Cell Res UR - https://doi.org/10.1038/s41422-020-0282-0 DO - 10.1038/s41422-020-0282-0 ID - Wang2020 ER - TY - JOUR AU - Gao, J. AU - Tian, Z. AU - Yang, X. PY - 2020 DA - 2020// TI - Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies JO - Biosci Trends. VL - 14 UR - https://doi.org/10.5582/bst.2020.01047 DO - 10.5582/bst.2020.01047 ID - Gao2020 ER - TY - STD TI - W. S. Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting (COPCOV). 2020. https://clinicaltrials.gov/ct2/show/NCT04303507. Accessed 11 Mar 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04303507 ID - ref40 ER - TY - JOUR AU - Ponticelli, C. AU - Moroni, G. PY - 2017 DA - 2017// TI - Hydroxychloroquine in systemic lupus erythematosus (SLE) JO - Expert Opin Drug Saf. VL - 16 UR - https://doi.org/10.1080/14740338.2017.1269168 DO - 10.1080/14740338.2017.1269168 ID - Ponticelli2017 ER - TY - JOUR AU - Schrezenmeier, E. AU - Dorner, T. PY - 2020 DA - 2020// TI - Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology JO - Nat Rev Rheumatol VL - 16 UR - https://doi.org/10.1038/s41584-020-0372-x DO - 10.1038/s41584-020-0372-x ID - Schrezenmeier2020 ER - TY - JOUR AU - Yao, X. AU - Ye, F. AU - Zhang, M. PY - 2020 DA - 2020// TI - In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) JO - Clin Infect Dis UR - https://doi.org/10.1093/cid/ciaa237 DO - 10.1093/cid/ciaa237 ID - Yao2020 ER - TY - STD TI - Hernandez-Cardenas. Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA). 2020. https://clinicaltrials.gov/ct2/show/NCT04315896. Accessed 20 Mar 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04315896 ID - ref44 ER - TY - JOUR AU - Uyeki, T. M. AU - Bernstein, H. H. AU - Bradley, J. S. PY - 2019 DA - 2019// TI - clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza JO - Clin Infect Dis VL - 68 UR - https://doi.org/10.1093/cid/ciy874 DO - 10.1093/cid/ciy874 ID - Uyeki2019 ER - TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30183-5 DO - 10.1016/S0140-6736(20)30183-5 ID - Huang2020 ER - TY - JOUR AU - Beigel, J. H. AU - Nam, H. H. AU - Adams, P. L. PY - 2019 DA - 2019// TI - Advances in respiratory virus therapeutics—A meeting report from the 6th isirv Antiviral Group conference JO - Antiviral Res VL - 167 UR - https://doi.org/10.1016/j.antiviral.2019.04.006 DO - 10.1016/j.antiviral.2019.04.006 ID - Beigel2019 ER - TY - JOUR AU - Chen, N. AU - Zhou, M. AU - Dong, X. PY - 2020 DA - 2020// TI - Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30211-7 DO - 10.1016/S0140-6736(20)30211-7 ID - Chen2020 ER - TY - JOUR AU - Zhao, Z. AU - Zhang, F. AU - Xu, M. PY - 2003 DA - 2003// TI - Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, P. R. China JO - J Med Microbiol. VL - 52 UR - https://doi.org/10.1099/jmm.0.05320-0 DO - 10.1099/jmm.0.05320-0 ID - Zhao2003 ER - TY - JOUR AU - Ho, J. C. AU - Ooi, G. C. AU - Mok, T. Y. PY - 2003 DA - 2003// TI - High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome JO - Am J Respir Crit Care Med VL - 168 UR - https://doi.org/10.1164/rccm.200306-766OC DO - 10.1164/rccm.200306-766OC ID - Ho2003 ER - TY - JOUR AU - Thompson, B. T. PY - 2003 DA - 2003// TI - Glucocorticoids and acute lung injury JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/01.CCM.0000057900.19201.55 DO - 10.1097/01.CCM.0000057900.19201.55 ID - Thompson2003 ER - TY - JOUR AU - Ni, Y. N. AU - Chen, G. AU - Sun, J. PY - 2019 DA - 2019// TI - The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis JO - Crit Care VL - 23 UR - https://doi.org/10.1186/s13054-019-2395-8 DO - 10.1186/s13054-019-2395-8 ID - Ni2019 ER - TY - JOUR AU - Yang, J. W. AU - Fan, L. C. AU - Miao, X. Y. PY - 2015 DA - 2015// TI - Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis JO - Clin Microbiol Infect VL - 21 UR - https://doi.org/10.1016/j.cmi.2015.06.022 DO - 10.1016/j.cmi.2015.06.022 ID - Yang2015 ER - TY - JOUR AU - Martin-Loeches, I. AU - Lisboa, T. AU - Rhodes, A. PY - 2011 DA - 2011// TI - Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection JO - Intensive Care Med VL - 37 UR - https://doi.org/10.1007/s00134-010-2078-z DO - 10.1007/s00134-010-2078-z ID - Martin-Loeches2011 ER - TY - JOUR AU - Giannella, M. AU - Alonso, M. AU - Garcia de Viedma, D. PY - 2011 DA - 2011// TI - Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients JO - Clin Microbiol Infect. VL - 17 UR - https://doi.org/10.1111/j.1469-0691.2010.03399.x DO - 10.1111/j.1469-0691.2010.03399.x ID - Giannella2011 ER - TY - JOUR AU - Wang, Y. AU - Guo, Q. AU - Yan, Z. PY - 2018 DA - 2018// TI - Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection JO - J Infect Dis VL - 217 UR - https://doi.org/10.1093/infdis/jiy115 DO - 10.1093/infdis/jiy115 ID - Wang2018 ER - TY - JOUR AU - Arabi, Y. M. AU - Mandourah, Y. AU - Al-Hameed, F. PY - 2018 DA - 2018// TI - Corticosteroid therapy for critically Ill patients with Middle East respiratory syndrome JO - Am J Respir Crit Care Med VL - 197 UR - https://doi.org/10.1164/rccm.201706-1172OC DO - 10.1164/rccm.201706-1172OC ID - Arabi2018 ER - TY - JOUR AU - Han, K. AU - Ma, H. AU - An, X. PY - 2011 DA - 2011// TI - Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection JO - Clin Infect Dis VL - 53 UR - https://doi.org/10.1093/cid/cir398 DO - 10.1093/cid/cir398 ID - Han2011 ER - TY - JOUR AU - Matteucci, C. AU - Grelli, S. AU - Balestrieri, E. PY - 2017 DA - 2017// TI - Thymosin alpha 1 and HIV-1: recent advances and future perspectives JO - Fut Microbiol. VL - 12 UR - https://doi.org/10.2217/fmb-2016-0125 DO - 10.2217/fmb-2016-0125 ID - Matteucci2017 ER - TY - JOUR AU - Pica, F. AU - Gaziano, R. AU - Casalinuovo, I. A. PY - 2018 DA - 2018// TI - Serum thymosin alpha 1 levels in normal and pathological conditions JO - Expert Opin Biol Ther. VL - 18 UR - https://doi.org/10.1080/14712598.2018.1474197 DO - 10.1080/14712598.2018.1474197 ID - Pica2018 ER - TY - JOUR AU - Wu, J. AU - Zhou, L. AU - Liu, J. PY - 2013 DA - 2013// TI - The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial JO - Crit Care VL - 17 UR - https://doi.org/10.1186/cc11932 DO - 10.1186/cc11932 ID - Wu2013 ER - TY - JOUR AU - Gao, Z. C. AU - Zhu, J. H. AU - Sun, Y. PY - 2003 DA - 2003// TI - Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome JO - Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. VL - 15 ID - Gao2003 ER - TY - JOUR AU - Dawar, F. U. AU - Tu, J. AU - Khattak, M. N. PY - 2017 DA - 2017// TI - Cyclophilin A: a key factor in virus replication and potential target for anti-viral therapy JO - Curr Issues Mol Biol. VL - 21 ID - Dawar2017 ER - TY - JOUR AU - Pfefferle, S. AU - Schopf, J. AU - Kogl, M. PY - 2011 DA - 2011// TI - The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors JO - PLoS Pathog VL - 7 UR - https://doi.org/10.1371/journal.ppat.1002331 DO - 10.1371/journal.ppat.1002331 ID - Pfefferle2011 ER - TY - JOUR AU - Morgenstern, B. AU - Michaelis, M. AU - Baer, P. C. PY - 2005 DA - 2005// TI - Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines JO - Biochem Biophys Res Commun VL - 326 UR - https://doi.org/10.1016/j.bbrc.2004.11.128 DO - 10.1016/j.bbrc.2004.11.128 ID - Morgenstern2005 ER - TY - JOUR AU - Mustafa, S. AU - Balkhy, H. AU - Gabere, M. N. PY - 2018 DA - 2018// TI - Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review JO - J Infect Public Health. VL - 11 UR - https://doi.org/10.1016/j.jiph.2017.08.009 DO - 10.1016/j.jiph.2017.08.009 ID - Mustafa2018 ER - TY - JOUR AU - Kuri, T. AU - Zhang, X. AU - Habjan, M. PY - 2009 DA - 2009// TI - Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation JO - J Gen Virol VL - 90 UR - https://doi.org/10.1099/vir.0.013599-0 DO - 10.1099/vir.0.013599-0 ID - Kuri2009 ER - TY - JOUR AU - Werdan, K. AU - Pilz, G. AU - Bujdoso, O. PY - 2007 DA - 2007// TI - Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study JO - Crit Care Med VL - 35 UR - https://doi.org/10.1097/01.CCM.0000297164.40980.F0 DO - 10.1097/01.CCM.0000297164.40980.F0 ID - Werdan2007 ER - TY - JOUR AU - Alejandria, M. M. AU - Lansang, M. A. AU - Dans, L. F. PY - 2013 DA - 2013// TI - Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock JO - Cochrane Database Syst Rev UR - https://doi.org/10.1002/14651858.CD001090.pub2(9):Cd001090 DO - 10.1002/14651858.CD001090.pub2(9):Cd001090 ID - Alejandria2013 ER - TY - JOUR AU - Chen, C. AU - Zhang, X. R. AU - Ju, Z. Y. PY - 2020 DA - 2020// TI - Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies JO - Zhonghua Shao Shang Za Zhi. VL - 36 ID - Chen2020 ER - TY - JOUR AU - Hoffman, E. AU - Rahat, M. A. AU - Feld, J. PY - 2019 DA - 2019// TI - Effects of Tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and Adipokine levels in patients with rheumatoid arthritis JO - Int J Mol Sci. VL - 20 ID - Hoffman2019 ER - TY - JOUR AU - Le, R. Q. AU - Li, L. AU - Yuan, W. PY - 2018 DA - 2018// TI - FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome JO - Oncologist. VL - 23 UR - https://doi.org/10.1634/theoncologist.2018-0028 DO - 10.1634/theoncologist.2018-0028 ID - Le2018 ER - TY - STD TI - Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). National Health Commission & State Administration of Traditional Chinese Medicine. 2020. http://healthcareus.sakura.ne.jp/wordpress/2020/03/17/diagnosis-and-treatment-protocol-for-novel-coronavirus-pneumonia-trial-version-7/. Accessed 17 Mar 2020. UR - http://healthcareus.sakura.ne.jp/wordpress/2020/03/17/diagnosis-and-treatment-protocol-for-novel-coronavirus-pneumonia-trial-version-7/ ID - ref73 ER - TY - JOUR AU - Liu, J. AU - Manheimer, E. AU - Shi, Y. PY - 2004 DA - 2004// TI - Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis JO - J Altern Complem Med. VL - 10 UR - https://doi.org/10.1089/acm.2004.10.1041 DO - 10.1089/acm.2004.10.1041 ID - Liu2004 ER - TY - JOUR AU - Ji, S. AU - Bai, Q. AU - Wu, X. PY - 2020 DA - 2020// TI - Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease JO - Biomed Pharmacother VL - 121 UR - https://doi.org/10.1016/j.biopha.2019.109652 DO - 10.1016/j.biopha.2019.109652 ID - Ji2020 ER - TY - JOUR AU - Ding, Y. AU - Zeng, L. AU - Li, R. PY - 2017 DA - 2017// TI - The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function JO - BMC Complement Altern Med. VL - 17 UR - https://doi.org/10.1186/s12906-017-1585-7 DO - 10.1186/s12906-017-1585-7 ID - Ding2017 ER - TY - JOUR AU - Du, C. Y. AU - Zheng, K. Y. AU - Bi, C. W. PY - 2015 DA - 2015// TI - Yu Ping Feng San, an ancient Chinese herbal decoction, induces gene expression of anti-viral proteins and inhibits neuraminidase activity JO - Phytother Res. VL - 29 UR - https://doi.org/10.1002/ptr.5290 DO - 10.1002/ptr.5290 ID - Du2015 ER - TY - JOUR AU - Wang, C. AU - Cao, B. AU - Liu, Q. Q. PY - 2011 DA - 2011// TI - Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial JO - Ann Intern Med VL - 155 UR - https://doi.org/10.7326/0003-4819-155-4-201108160-00005 DO - 10.7326/0003-4819-155-4-201108160-00005 ID - Wang2011 ER - TY - JOUR AU - Marano, G. AU - Vaglio, S. AU - Pupella, S. PY - 2016 DA - 2016// TI - Convalescent plasma: new evidence for an old therapeutic tool? JO - Blood Trans. VL - 14 ID - Marano2016 ER - TY - JOUR AU - Burnouf, T. AU - Conton, B. AU - Dye, J. M. PY - 2016 DA - 2016// TI - Convalescent plasma for Ebola virus disease JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMc1602284 DO - 10.1056/NEJMc1602284 ID - Burnouf2016 ER - TY - JOUR AU - Soo, Y. O. AU - Cheng, Y. AU - Wong, R. PY - 2004 DA - 2004// TI - Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients JO - Clin Microbiol Infect VL - 10 UR - https://doi.org/10.1111/j.1469-0691.2004.00956.x DO - 10.1111/j.1469-0691.2004.00956.x ID - Soo2004 ER - TY - JOUR AU - Cheng, Y. AU - Wong, R. AU - Soo, Y. O. PY - 2005 DA - 2005// TI - Use of convalescent plasma therapy in SARS patients in Hong Kong JO - Eur J Clin Microbiol Infect Dis VL - 24 UR - https://doi.org/10.1007/s10096-004-1271-9 DO - 10.1007/s10096-004-1271-9 ID - Cheng2005 ER - TY - JOUR AU - Lu, C. L. AU - Murakowski, D. K. AU - Bournazos, S. PY - 2016 DA - 2016// TI - Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo JO - Science VL - 352 UR - https://doi.org/10.1126/science.aaf1279 DO - 10.1126/science.aaf1279 ID - Lu2016 ER - TY - JOUR AU - Zhao, J. AU - Perera, R. A. AU - Kayali, G. PY - 2015 DA - 2015// TI - Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection JO - J Virol VL - 89 UR - https://doi.org/10.1128/JVI.00446-15 DO - 10.1128/JVI.00446-15 ID - Zhao2015 ER - TY - JOUR AU - Chen, L. AU - Xiong, J. AU - Bao, L. PY - 2020 DA - 2020// TI - Convalescent plasma as a potential therapy for COVID-19 JO - Lancet Infect Dis UR - https://doi.org/10.1016/s1473-3099(20)30141-9 DO - 10.1016/s1473-3099(20)30141-9 ID - Chen2020 ER - TY - JOUR AU - Fowler, R. A. AU - Lapinsky, S. E. AU - Hallett, D. PY - 2003 DA - 2003// TI - Critically ill patients with severe acute respiratory syndrome JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.3.367 DO - 10.1001/jama.290.3.367 ID - Fowler2003 ER - TY - JOUR AU - Kumar, A. AU - Zarychanski, R. AU - Pinto, R. PY - 2009 DA - 2009// TI - Critically ill patients with 2009 influenza A(H1N1) infection in Canada JO - JAMA VL - 302 UR - https://doi.org/10.1001/jama.2009.1496 DO - 10.1001/jama.2009.1496 ID - Kumar2009 ER - TY - JOUR AU - Rochwerg, B. AU - Brochard, L. AU - Elliott, M. W. PY - 2017 DA - 2017// TI - Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure JO - Eur Respir J. VL - 50 UR - https://doi.org/10.1183/13993003.02426-2016 DO - 10.1183/13993003.02426-2016 ID - Rochwerg2017 ER - TY - JOUR AU - Frat, J. P. AU - Thille, A. W. AU - Mercat, A. PY - 2015 DA - 2015// TI - High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1503326 DO - 10.1056/NEJMoa1503326 ID - Frat2015 ER - TY - JOUR AU - Hui, D. S. AU - Chow, B. K. AU - Lo, T. PY - 2019 DA - 2019// TI - Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks JO - Eur Respir J. VL - 53 UR - https://doi.org/10.1183/13993003.02339-2018 DO - 10.1183/13993003.02339-2018 ID - Hui2019 ER - TY - JOUR AU - Hui, D. S. AU - Chow, B. K. AU - Chu, L. PY - 2012 DA - 2012// TI - Exhaled air dispersion during coughing with and without wearing a surgical or N95 mask JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0050845 DO - 10.1371/journal.pone.0050845 ID - Hui2012 ER - TY - JOUR PY - 2020 DA - 2020// TI - Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia JO - Zhonghua Jie He He Hu Xi Za Zhi. VL - 17 ID - ref92 ER - TY - JOUR AU - Alhazzani, W. AU - Moller, M. H. AU - Arabi, Y. M. PY - 2020 DA - 2020// TI - Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) JO - Intensive Care Med UR - https://doi.org/10.1007/s00134-020-06022-5 DO - 10.1007/s00134-020-06022-5 ID - Alhazzani2020 ER - TY - JOUR AU - Guérin, C. AU - Reignier, J. AU - Richard, J. -. C. PY - 2013 DA - 2013// TI - Prone positioning in severe acute respiratory distress syndrome JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214103 DO - 10.1056/NEJMoa1214103 ID - Guérin2013 ER - TY - JOUR AU - Xu, Y. AU - Deng, X. AU - Han, Y. PY - 2015 DA - 2015// TI - A multicenter retrospective review of prone position ventilation (PPV) in treatment of severe human H7N9 Avian flu JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0136520 DO - 10.1371/journal.pone.0136520 ID - Xu2015 ER - TY - JOUR AU - Noah, M. A. AU - Peek, G. J. AU - Finney, S. J. PY - 2011 DA - 2011// TI - Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1) JO - JAMA VL - 306 UR - https://doi.org/10.1001/jama.2011.1471 DO - 10.1001/jama.2011.1471 ID - Noah2011 ER - TY - JOUR AU - Alshahrani, M. S. AU - Sindi, A. AU - Alshamsi, F. PY - 2018 DA - 2018// TI - Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus JO - Ann Intensive Care. VL - 8 UR - https://doi.org/10.1186/s13613-017-0350-x DO - 10.1186/s13613-017-0350-x ID - Alshahrani2018 ER - TY - JOUR AU - MacLaren, G. AU - Fisher, D. AU - Brodie, D. PY - 2020 DA - 2020// TI - Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation JO - JAMA UR - https://doi.org/10.1001/jama.2020.2342 DO - 10.1001/jama.2020.2342 ID - MacLaren2020 ER - TY - JOUR AU - Poston, J. T. AU - Patel, B. K. AU - Davis, A. M. PY - 2020 DA - 2020// TI - Management of critically ill adults with COVID-19 JO - JAMA UR - https://doi.org/10.1001/jama.2020.4914 DO - 10.1001/jama.2020.4914 ID - Poston2020 ER -